Quarterly Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7732882

Concept As at
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-638,472,000 JPY
Interest and dividends received
23,000 JPY
Income taxes paid
-3,255,000 JPY
Net cash provided by (used in) operating activities
-641,404,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-30,745,000 JPY
Net cash provided by (used in) investing activities
-32,120,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
10,680,000 JPY
Net increase (decrease) in cash and cash equivalents
-662,844,000 JPY
Cash and cash equivalents
4,287,725,000 JPY
4,950,570,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.